P28066 (PSA5_HUMAN) Homo sapiens (Human)

Proteasome subunit alpha type-5 UniProtKBInterProSTRINGInteractive Modelling

241 aa; Sequence (Fasta) ; (Isoform 2); 85 identical sequences

Available Structures

57 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
human PA200-20S complex Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436;
K0W;IHP;1-241
Assess
Human 20S-PA200 Proteasome Complex Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436;
IHP;K0W;1-241
Assess
Akirin2 bound human proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q53H80; Q99436;
K;1-241
Assess
Structure of human 20S proteasome with bound MPI-5 Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
YHD;6-241
Assess
Human Constitutive 20S Proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
8-241
Assess
Crystal Structure of the mammalian 20S proteasome at 2.75 A resolution Heteromer
P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
30×MG;8-241
Assess
Human constitutive 20S proteasome in complex with carfilzomib Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
3BV;8-241
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;MG;ADP;8-241
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
8-241
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;ATP;MG;8-241
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;MG;ADP;8-241
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;8-241
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;MG;ADP;8-241
Assess
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ATP;ZN;8-241
Assess
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ADP;ZN;8-241
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;MG;ADP;8-241
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;8-241
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;8-241
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;MG;ADP;8-241
Assess
Human 20S proteasome bound to an engineered 11S (PA26) activator Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; Q9U8G2;
8-241
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;ADP;8-241
Assess
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ATP;ZN;8-241
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;8-241
Assess
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ATP;ZN;8-241
Assess
Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;8-241
Assess
PA28alpha-beta in complex with immunoproteasome Heteromer
P33672; Q06323; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; Q9UL46;
8-241
Assess
bovine 20S immunoproteasome Heteromer
P33672; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
8-241
Assess
SD-like state of human 26S Proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin l… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;8-241
Assess
SA-like state of human 26S Proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin l… Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG48; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;MG;ADP;8-241
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;8-241
Assess
Bovine 20S immunoproteasome in complex with two human PA28alpha-beta activators Heteromer
P33672; Q06323; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; Q9UL46;
8-241
Assess
The human 26S proteasome at 3.9 A Heteromer
O14818; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P49720; P49721; P60900; P62191; P62195; P62333; Q99436;
ATP;MG;ADP;8-241
Assess
Structure of the human 26S proteasome bound to USP14-UbAl Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ADP;8-241
Assess
Native human 20S proteasome at 1.8 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
57×CL;1PE;K; 10×MG;9-241
Assess
Human 20S proteasome complex with Oprozomib at 1.9 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
58×CL;K; 10×MG;1PE;9-241
Assess
Human 20S proteasome complex with Delanzomib at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
52×CL;K; 10×MG;1PE;6V7;9-241
Assess
Human 20S proteasome complex with Ixazomib at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
51×CL;K; 10×MG;1PE;6V8;9-241
Assess
Human 20S proteasome complex with Dihydroeponemycin at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
56×CL;K; 10×MG;1PE;6VC;9-241
Assess
Human 20S proteasome complex with Z-LLY-ketoaldehyde at 2.1 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
55×CL;K; 10×MG;1PE;PHQ;9-241
Assess
Human 20S proteasome complex with Bortezomib at 2.1 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
51×CL;K; 10×MG;1PE;BO2;9-241
Assess
Human 20S proteasome complex with Oprozomib in Mg-Acetate at 2.2 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K; 10×MG;1PE;ACT;9-241
Assess
Native human 20S proteasome in Mg-Acetate at 2.2 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;MG;1PE;9-241
Assess
Human 20S proteasome complex with Epoxomicin at 2.4 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
58×CL;K; 10×MG;1PE;9-241
Assess
Mouse 20S immunoproteasome in complex with PR-957 Heteromer
O09061; O35955; O70435; P28063; P28076; P49722; P99026; Q9QUM9; Q9R1P0; Q9R1P1; Q9R1P3; Q9R1P4; Q9Z2U0; Q9Z2U1;
41×CL; 13×K;04C;IOD;9-241
Assess
Mouse constitutive 20S proteasome in complex with PR-957 Heteromer
O09061; O55234; O70435; P49722; P70195; P99026; Q60692; Q9QUM9; Q9R1P0; Q9R1P1; Q9R1P3; Q9R1P4; Q9Z2U0; Q9Z2U1;
04C;9-241
Assess
Mouse constitutive 20S proteasome Heteromer
O09061; O55234; O70435; P49722; P70195; P99026; Q60692; Q9QUM9; Q9R1P0; Q9R1P1; Q9R1P3; Q9R1P4; Q9Z2U0; Q9Z2U1;
9-241
Assess
Mouse 20S immunoproteasome Heteromer
O09061; O35955; O70435; P28063; P28076; P49722; P99026; Q9QUM9; Q9R1P0; Q9R1P1; Q9R1P3; Q9R1P4; Q9Z2U0; Q9Z2U1;
14×IOD; 23×CL; 10×K;9-241
Assess
Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively … Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28070; P40306; P49720; P49721; P60900;
BZ7;9-241
Assess
Endogeneous native human 20S proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
Assess
Human 20S Proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
Assess
Human 26S proteasome in complex with Oprozomib Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q15008; Q99436; Q99460; Q9UNM6;
ADP;9-241
Assess
20S+monoUb-CyclinB1-NT (S1) Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
Assess
20S+monoUb-CyclinB1-NT (S2) Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
9-241
Assess
HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH [(1R)-2-(1-benzofuran-3-yl)-1-{[(1S,2R,4R)-7-ox… Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28070; P40306; P49720; P49721; P60900;
13×NA; 11×SCN;S5K;9-240
Assess
Human Immunoproteasome 20S particle in complex with compound 1 Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28062; P28065; P28070; P40306; P49720; P49721; P60900;
SCN; 12×NA;HUJ;9-240
Assess
The human 26S Proteasome at 6.8 Ang. Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
10-241
Assess
Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core Heteromer
O14818; P20618; P25786; P25787; P25788; P25789; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
KNM;13-236
Assess

1 Homology model

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomer0.833unh.1.D9-241
100.00
Assess

1 Homology model built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 2monomer0.833unh.1.D1-183
100.00
Assess

Alignments